We observed in the ME/CFS patients an increased NK CD56++(high) population (p = 0.0075), a small group of NK cells (maximum 10%) with greater cytokine secretion capacity, particularly IFNγ, and with low cytotoxic activity (44, 45). The gene discussed is IFNG; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.